1. PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA. (June 2017) Authors: Blakemore, S.J.; Daigle, S.R.; McDonald, A.A.; Morschhauser, F.; Ribrag, V.; Salles, G.; McKay, P.; Tilly, H.; Schmitt, A.; Le Gouill, S.; Fruchart, C.; Radford, J.; Zinzani, P.L.; Assouline, S.; Cartron, G.; Dickinson, M.; Morin, R.; Wu, H.; Sausen, M.; Clawson, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗